A study by Suto et al. in 2004 also suggested that a dominant mutant of JUN inhibits the activity of the transcription factor AP-1 and is thus helpful for relieving colon cancer tumorigenesis [89]. The gene discussed is JUN; the disease is colonic neoplasm.